Embed Size (px)
Citation preview
Biobetters 2018
http://biobetters.conferenceseries.com
conferenceseries LLC Ltd
***For available speaker slots***
http://biobetters.conferenceseries.com
Tentative Program
Biobetters and Regulatory AffairsJune 27-28, 2018 | Vancouver, Canada
International Conference on
InteractiveSessions
KeynoteLectures
PlenaryLectures Exhibitors B2B
Meetings Workshops
08:30‐09:00 Registrations09:00‐09:30 INTRODUCTION
Title: Biobetters vs Biosimilars: Opportunities, threats & strategic implications Dr.Gregory K Bell, Charles River Associates, USATitle: The impact of Pharmacogenomics on the future development of Biological TherapeuticsMichael D Winther, Genome Institute of Singapore, SingaporeTitle: Corporate Integrity in the Medical Research and Pharmaceuticals Industries: the SEC’s Whistleblower ProgramSteven J. Durham, Labaton Sucharow LLP, USA
Title: The Evolving Landscape of Biobetters: Advantages & Challenges of Being BetterKouros Motamed, NantBioscience Inc., USATitle: Treatment of Human Lysosomal Storage Disorders with Blood‐Brain Barrier Penetrating IgG‐fusion ProteinsRuben Boado, Armagen, USATitle: Biobetters, Regulatory Frameworks and the ‘Right to Health’ in Africa Professor Mandla S. Makhanya, University of South Africa, South Africa
Title: The Evolving Landscape of Biobetters: Advantages & Challenges of Being BetterKouros Motamed, NantBioscience Inc., USATitle: Biosimilars: Challenges in Safety and Risk ManagementAsif Mahmood, Pfizer, USATitle: Icotinib inhibits EGFR signaling and alleviates psoriasis‐like symptoms in animal modelsFenlai Tan, Betta Pharmaceutical Co Ltd, Hangzhou, ChinaTitle: Quality Management and Quality Audit According to GxP/GMP RequirementsEleonora Babayants, President, Galaxy Consulting, Redwood City, USATitle: Biobetters, they had better be better William R Strohl, BiStro Biotech Consulting, USA
Title: Pharmacists role in helping patients with Biosimilars,education, adherence, and appropriate monitoringAlan Low, CanadaTitle: Counterfeiting Drugs Set Alarm Bells Ringing: Comparative Analysis of Drug PoliciesAbdeen Mustafa Omer, Ministry of Health and Social Welfare, Sudan
09:00‐09:30 Registrations
Title : Biosimilar by approval – biogenerics in practice? Steinar Madsen, MD, Norwegian Medicines Agency
Title : Cancer stem cell research in Iran: potentials and challengesZahra Madjd, Iran
Day 2 @
Day 1 @
27‐Jun‐18
Keynote Forum
09:30‐10:00
12:05‐12:35
12:35‐13:05
Lunch Break
10:00‐10:30
10:30‐11:00
Networking and Refreshment
11:20‐12:05
27‐Jun‐18
Keynote Forum
09:30‐ 10:00
10:00‐ 10:30
11:00‐ 11:20 Networking and Refreshment
13:45‐14:15
14:15‐14:45
14:45‐15:15
15:15‐15:45
15:45‐16:15
16:15‐ 16:30 Networking and Refreshment
16:30‐ 17:00
Panel Discussion & Closing Ceremony
17:00‐ 17:30
International Conference on
Biobetters and Regulatory AffairsTentative Program
International Conference on
Title: Identification and in silico analysis of functional SNPs of human TAGAP protein: A comprehensive studyMaria Arshad,National University of Sciences & Technology, PakistanTitle: Evaluation of the antimicrobial effect of expired oral antibiotics In‐Vitro Kawthar Alghasham, UWA, AustraliaTitle: Exploring the Link between Gene Dynamics and Intimal Hyperplasia – A MultiScale Model of Vascular AdaptationStefano Casarin,Houston Methodist Research Institute, USA
Title : Time to consider "biobettering" FMO2‐mediated anti‐tubercular drugs?EPHREM MEKONNEN, ADDIS ABABA UNIVERSITY, ETHIOPIATitle: Association between diabetes mellitus and active tuberculosis: a systematic review and meta‐analysisRami H. Al‐Rifai ,QatarTitle :Traditional Medicine in Public Health in Azad Jammu and Kashmir: Role of Economic resources of TCMsMaryam Akram Butt, Quaid‐i‐Azam University,PakistanTitle: International Funding and Mobility Programmes in Life SciencesJale SAHIN ,The Scientific and Technological Research Council of Turkey, TURKEY
Title: Human Metapneumovirus A/B acute respiratory infections in children in a Central‐East region of TunisiaInes Brini, University of Sousse, TunisiaTitle: GxP/GMP and its Consequences for Documentation and Information Technology Systems
Eleonora Babayants, President, Galaxy Consulting, USA
Title: Profitability and Value Of Biosimilars and BiobettersJoachim M.Greuel, Bioscience Valuation
Video presention
17:30‐18:00
Panel Discussion & Closing Ceremony
16:45‐ 17:15
16:15‐ 16:45
14:00‐14:30
14:30‐ 15:00
15:00‐ 15:30
15:30‐ 16:00
16:00‐ 16:15 Networking and Refreshment
11:20‐ 12:05
12:05‐12:35
12:35‐13:05
13:05‐ 14:00 Lunch Brea
Biobetters and Regulatory AffairsTentative Program
Biobetters 2018 conferenceseries LLC Ltd
http://biobetters.conferenceseries.com
Vancouver is a coastal seaport city in Canada, located in the Lower Mainland region of British
Columbia. As the most populous city in the province, the 2016 census recorded 631,486 people in
the city, up from 603,502 in 2011. The Greater Vancouver area had a population of 2,463,431
in 2016, making it the third-largest metropolitan area in Canada. Vancouver has the highest
population density in Canada with over 5,400 people per square kilometre. With over 250,000
residents, Vancouver is the fourth most densely populated city in North America behind New York
City, San Francisco, and Mexico City according to the 2011 census. Vancouver is one of the most
ethnically and linguistically diverse cities in Canada according to that census; 52% of its residents
have a first language other than English. Vancouver is classed as a Beta global city.
About Vancouver, Canada
Biobetters 2018 conferenceseries LLC Ltd
http://biobetters.conferenceseries.com
Plan your Trip to Vancouver, Canada
Bloedel Floral Conservatory
Jericho Beach
Moraine Lake
Queen Elizabeth Park
Capilano Suspension Bridge
Light House Park
Playland
Vancouver Aquarium
Biobetters 2018 conferenceseries LLC Ltd
http://biobetters.conferenceseries.com
• Generic Drug Marketing strategy• Drug Discovery & Designing• Biobetters Vs Biosimilars• Generic Drugs• Building Biobetters :The regulatory
landscape• The structure of proteins• Biosimilar Development: Principles
and Pitfalls• Opportunities & Challenges from a
Market
• Regulatory Essentials• Regulatory Affairs and IPR• Regulatory Strategy Forum for
Medical Devices• Regional Regulatory Update Of US
&EU• Regional Regulatory Update of GCC,
ASIA and AFRICA
Major Scientific Sessions
• You will be given about 5-7 minutes to present your poster including questions and answers.
Judges may pose questions during the evaluation of the poster
• Judges will even evaluate the student’s enthusiasm towards their study, interest and knowledge in the area of their research
• The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement
• Apart from the judging time you may also be present at the poster to share your research with interested delegates
• Present your research through oral presentations
• Learn about career development and the latest research tools and technologies in your field
• This forum will give pertinent and timely information to those who conduct research and those who use and benefit from research
• Develop a foundation for collaboration among young researchers
• The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe Interact and share ideas with both peers and mentors
Best Poster Award Young Researchers Forum
Conference Venue: Vancouver, Canada
Conference Series LLC Ltd 47 Churchfield Road, London, UK, W3 6AY
Toll Free: +1-800-014-8923Email: [email protected]
Conference Series LLC Ltd - Asia Pacific 6th Floor, North Block, Divyasree Building, Raidurg,
Hyderabad, INDIA-500032 P: +91-40-33432300 Email: [email protected]
General [email protected]
